tiprankstipranks
Alibaba Health Information Technology Ltd. (HK:0241)
:0241
Hong Kong Market

Alibaba Health Information Technology (0241) Ratios

24 Followers

Alibaba Health Information Technology Ratios

HK:0241's free cash flow for Q2 2026 was ¥0.25. For the 2026 fiscal year, HK:0241's free cash flow was decreased by ¥ and operating cash flow was ¥0.09. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
2.71 2.59 2.69 2.74 2.81
Quick Ratio
2.34 2.29 2.41 2.36 2.49
Cash Ratio
0.89 0.47 0.69 2.01 2.19
Solvency Ratio
0.34 0.31 0.18 0.10 -0.04
Operating Cash Flow Ratio
0.29 0.29 0.21 0.05 0.09
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 9.33B¥ 7.41B¥ 8.32B¥ 9.31B¥ 8.44B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.32 1.30 1.35 1.37 1.36
Debt Service Coverage Ratio
2.82K 571.95 157.95 -6.68 -52.83
Interest Coverage Ratio
2.64K 604.09 120.19 -5.45 -287.93
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Net Debt to EBITDA
-2.25 -1.35 -3.41 442.84 55.35
Profitability Margins
Gross Profit Margin
24.45%24.29%21.81%21.30%19.96%
EBIT Margin
6.44%5.11%3.50%-0.19%-1.21%
EBITDA Margin
6.56%5.30%3.70%-0.09%-0.91%
Operating Profit Margin
5.48%5.15%2.65%-0.12%-5.34%
Pretax Profit Margin
6.56%5.10%3.48%2.06%-1.23%
Net Profit Margin
5.84%4.68%3.27%2.00%-1.29%
Continuous Operations Profit Margin
5.84%4.68%3.27%2.00%-1.29%
Net Income Per EBT
89.00%91.82%94.05%97.22%105.16%
EBT Per EBIT
119.60%98.98%130.94%-1733.39%22.99%
Return on Assets (ROA)
8.26%6.76%4.48%2.58%-1.38%
Return on Equity (ROE)
11.49%8.78%6.07%3.53%-1.88%
Return on Capital Employed (ROCE)
10.19%9.59%4.89%-0.21%-7.64%
Return on Invested Capital (ROIC)
9.05%8.80%4.58%-0.20%-7.63%
Return on Tangible Assets
8.70%7.13%4.75%2.73%-1.47%
Earnings Yield
2.79%2.03%2.21%0.80%-0.48%
Efficiency Ratios
Receivables Turnover
10.36 14.76 14.14 46.24 39.88
Payables Turnover
6.35 8.12 6.31 5.67 4.67
Inventory Turnover
12.01 16.37 15.10 10.02 10.62
Fixed Asset Turnover
300.96 438.87 260.71 390.43 124.63
Asset Turnover
1.41 1.44 1.37 1.29 1.07
Working Capital Turnover Ratio
3.87 3.82 3.01 2.94 2.11
Cash Conversion Cycle
8.18 2.09 -7.89 -20.04 -34.69
Days of Sales Outstanding
35.23 24.73 25.81 7.89 9.15
Days of Inventory Outstanding
30.40 22.30 24.18 36.43 34.35
Days of Payables Outstanding
57.45 44.94 57.87 64.36 78.20
Operating Cycle
65.63 47.03 49.99 44.33 43.51
Cash Flow Ratios
Operating Cash Flow Per Share
0.10 0.09 0.08 0.02 0.03
Free Cash Flow Per Share
0.10 0.09 0.08 0.02 0.03
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 0.99 0.98 0.98 0.96
Dividend Paid and CapEx Coverage Ratio
554.95 73.80 47.40 45.56 28.42
Capital Expenditure Coverage Ratio
554.95 73.80 47.40 45.56 28.42
Operating Cash Flow Coverage Ratio
21.10 39.28 13.14 3.29 3.13
Operating Cash Flow to Sales Ratio
0.05 0.05 0.04 <0.01 0.02
Free Cash Flow Yield
2.32%1.95%2.65%0.37%0.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
34.64 49.26 45.22 125.22 -208.70
Price-to-Sales (P/S) Ratio
2.02 2.31 1.48 2.51 2.69
Price-to-Book (P/B) Ratio
3.79 4.33 2.75 4.42 3.93
Price-to-Free Cash Flow (P/FCF) Ratio
41.64 51.28 37.80 268.20 135.36
Price-to-Operating Cash Flow Ratio
41.56 50.59 37.00 262.32 130.60
Price-to-Earnings Growth (PEG) Ratio
0.35 1.17 0.78 -0.42 1.19
Price-to-Fair Value
3.79 4.33 2.75 4.42 3.93
Enterprise Value Multiple
28.57 42.21 36.58 -2.30K -239.26
Enterprise Value
64.00B 68.39B 36.55B 56.23B 45.01B
EV to EBITDA
29.63 42.21 36.58 -2.30K -239.26
EV to Sales
1.94 2.23 1.35 2.10 2.19
EV to Free Cash Flow
40.03 49.69 34.57 224.86 109.93
EV to Operating Cash Flow
39.96 49.02 33.84 219.92 106.06
Tangible Book Value Per Share
1.02 0.95 0.95 1.04 0.96
Shareholders’ Equity Per Share
1.09 1.02 1.03 1.12 1.05
Tax and Other Ratios
Effective Tax Rate
0.11 0.08 0.06 0.03 -0.05
Revenue Per Share
2.04 1.90 1.92 1.98 1.53
Net Income Per Share
0.12 0.09 0.06 0.04 -0.02
Tax Burden
0.89 0.92 0.94 0.97 1.05
Interest Burden
1.02 1.00 0.99 -10.70 1.02
Research & Development to Revenue
0.02 0.02 0.03 0.03 0.04
SG&A to Revenue
0.17 0.09 0.01 0.01 0.02
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.01 0.02
Income Quality
0.83 0.89 1.15 0.48 -1.60
Currency in CNY